135 related articles for article (PubMed ID: 7042134)
1. Photochemotherapy in psoriasis-clinical response and 8-MOP plasma concentrations at two dose levels.
Andrew E; Nilsen A; Thune P; Wiik I
Clin Exp Dermatol; 1981 Nov; 6(6):591-600. PubMed ID: 7042134
[No Abstract] [Full Text] [Related]
2. Microenema of 8-methoxypsoralen in photochemotherapy of psoriasis.
Siddiqui AH; Stolk L; Korthals Altes-Levij van Vinninghe HR; Kammeijer A; Cormane RH
Arch Dermatol Res; 1982; 273(3-4):219-23. PubMed ID: 7165351
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of 8-methoxypsoralen in psoriatic patients receiving topical 8-methoxypsoralen.
Neild VS; Scott LV
Br J Dermatol; 1982 Feb; 106(2):199-203. PubMed ID: 7059510
[TBL] [Abstract][Full Text] [Related]
4. Comparison of serum levels and clinical results of PUVA therapy with three different dosage forms of 8-methoxypsoralen.
Siddiqui AH; Stolk LM; Cormane RH
Arch Dermatol Res; 1984; 276(5):343-5. PubMed ID: 6486881
[No Abstract] [Full Text] [Related]
5. Dietary influences on 8-MOP plasma levels in PUVA patients with psoriasis.
Roelandts R; Van Boven M; Deheyn T; Vander Stichele G; Degreef H; Daenens P
Br J Dermatol; 1981 Nov; 105(5):569-72. PubMed ID: 7295571
[TBL] [Abstract][Full Text] [Related]
6. Plasma 8-methoxypsoralen concentrations in photochemotherapy of psoriasis.
Stevenson IH; Kenicer KJ; Johnson BE; Frain-Bell W
Br J Dermatol; 1981 Jan; 104(1):47-51. PubMed ID: 7459268
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of 8-methoxypsoralen after bath-PUVA for psoriasis: relationship to disease severity.
Gómez MI; Azaña JM; Arranz I; Harto A; Ledo A
Br J Dermatol; 1995 Jul; 133(1):37-40. PubMed ID: 7669638
[TBL] [Abstract][Full Text] [Related]
8. Minimal phototoxic doses and 8-MOP plasma levels in PUVA patients.
Goldstein DP; Carter DM; Ljunggren B; Burkholder J
J Invest Dermatol; 1982 May; 78(5):429-33. PubMed ID: 7069220
[No Abstract] [Full Text] [Related]
9. 8-MOP plasma levels in PUVA problem cases with psoriasis.
Wagner G; Hofmann C; Busch U; Schmid J; Plewig G
Br J Dermatol; 1979 Sep; 101(3):285-92. PubMed ID: 508594
[TBL] [Abstract][Full Text] [Related]
10. Comparison of bioavailability and phototoxicity of two oral preparations of 5-methoxypsoralen.
Stolk LM; Siddiqui AH; Westerhof W; Cormane RH
Br J Dermatol; 1985 Apr; 112(4):469-73. PubMed ID: 3994922
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of 8-methoxypsoralen and phototoxicity studies during PUVA treatment of psoriasis with meladinin tablets.
Thune P
Acta Derm Venereol; 1978; 58(2):149-51. PubMed ID: 76395
[TBL] [Abstract][Full Text] [Related]
12. [8-Methoxypsoralen (8-MOP)-a new galenic form and its relation to 8-MOP serum levels (author's transl)].
Nitsche V; Raff M; Bardach H
Arch Dermatol Res; 1981; 271(1):11-7. PubMed ID: 7294879
[TBL] [Abstract][Full Text] [Related]
13. Standardizing 8-methoxypsoralen plasma profiles by using an emulsion form.
Van Boven M; Roelandts R; Adriaens P; Daenens P; Degreef H; Kinget R
J Am Acad Dermatol; 1985 May; 12(5 Pt 1):822-7. PubMed ID: 4008686
[TBL] [Abstract][Full Text] [Related]
14. Calculation of 8-methoxypsoralen dose according to body surface area in PUVA treatment.
Sakuntabhai A; Diffey BL; Farr PM
Br J Dermatol; 1995 Dec; 133(6):919-23. PubMed ID: 8547045
[TBL] [Abstract][Full Text] [Related]
15. Minimal phototoxic doses of 8-MOP plasma levels in PUVA patients.
De Bersagues J
J Invest Dermatol; 1983 Apr; 80(4):300. PubMed ID: 6833787
[No Abstract] [Full Text] [Related]
16. [Psoriasis treatment by a photochemotherapy (PUVA) method].
Babaian RS; Vladimirov VV; Kulikova EP; Panichkina GS
Vestn Dermatol Venerol; 1980 Oct; (10):4-7. PubMed ID: 6449792
[No Abstract] [Full Text] [Related]
17. Serum 8-methoxypsoralen (8-MOP) concentrations after bath water delivery of 8-MOP plus UVA.
David M; Lowe NJ; Halder RM; Borok M
J Am Acad Dermatol; 1990 Nov; 23(5 Pt 1):931-2. PubMed ID: 2254480
[No Abstract] [Full Text] [Related]
18. Serum levels of 8-methoxypsoralen in two different drug preparations: correlation with photosensitivity and UV-A dose requirements for photochemotherapy.
Hönigsmann H; Jaschke E; Nitsche V; Brenner W; Rauschmeier W; Wolff K
J Invest Dermatol; 1982 Oct; 79(4):233-6. PubMed ID: 7130741
[TBL] [Abstract][Full Text] [Related]
19. Initial photochemotherapy of psoriasis with orally administered 8-methoxypsoralen and longwave ultraviolet light (PUVA).
Siddiqui AH; Cormane RH
Br J Dermatol; 1979 Mar; 100(3):247-50. PubMed ID: 435382
[TBL] [Abstract][Full Text] [Related]
20. 5-Methoxypsoralen (Bergapten) in photochemotherapy of psoriasis.
Hönigsmann H; Jaschke E; Gschnait F; Brenner W; Fritsch P; Wolff K
Br J Dermatol; 1979 Oct; 101(4):369-78. PubMed ID: 508604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
